发明申请
- 专利标题: QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
- 专利标题(中): 喹诺酮作为钾离子通道抑制剂
-
申请号: US13393328申请日: 2010-09-01
-
公开(公告)号: US20120232068A1公开(公告)日: 2012-09-13
- 发明人: James A. Johnson , John Lloyd , Heather Finlay , Ji Jiang , James Neels , Naveen Kumar Dhondi , Prashantha Gunaga , Abhisek Banerjee
- 申请人: James A. Johnson , John Lloyd , Heather Finlay , Ji Jiang , James Neels , Naveen Kumar Dhondi , Prashantha Gunaga , Abhisek Banerjee
- 申请人地址: US NJ Princeton
- 专利权人: Briston-Myers Squibb Company
- 当前专利权人: Briston-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 国际申请: PCT/US10/47430 WO 20100901
- 主分类号: A61K31/517
- IPC分类号: A61K31/517 ; C07D413/12 ; A61P9/06 ; C07D513/04 ; A61K31/549 ; C07D401/14 ; A61K31/5377
摘要:
A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur associated disorders, and other disorders mediated by ion channel function.
公开/授权文献
- US08575184B2 Quinazolines as potassium ion channel inhibitors 公开/授权日:2013-11-05
信息查询
IPC分类: